Amylin

Amylin, or Islet Amyloid Polypeptide (IAPP), is a 37-residue peptide hormone secreted by pancreatic β-cells at the same time as insulin (in a roughly 100:1 ratio).

PBB_Summary
section_title =
summary_text = Islet, or insulinoma, amyloid polypeptide (IAPP, or amylin) is commonly found in pancreatic islets of patients suffering diabetes mellitus type 2, or harboring an insulinoma. While the association of amylin with the development of type 2 diabetes has been known for some time, a direct causative role for amylin has been harder to establish. Recent results suggest that amylin, like the related beta-amyloid (Abeta) assosciated with Alzheimer's disease, can induce apoptotic cell-death in particular cultured cells, an effect that may be relevant to the development of type 2 diabetes. [cite web | title = Entrez Gene: IAPP islet amyloid polypeptide| url = http://www.ncbi.nlm.nih.gov/sites/entrez?Db=gene&Cmd=ShowDetailView&TermToSearch=3375| accessdate = ]

Function

Amylin functions as part of the endocrine pancreas and contributes to glycemic control. Amylin's metabolic function is now somewhat well characterized as an inhibitor of the appearance of nutrient [especially glucose] in the plasma. It thus functions as a synergistic partner to insulin, with which it is cosecreted from pancreatic beta cells in response to meals. The overall effect to slow the rate of appearance (Ra) from the meal is mediated via a coordinate reduction of food intake, slowing of gastric emptying, inhibition of digestive secretion [gastric acid, pancreatic enzymes, and bile ejection] . Appearance of new glucose is slowed by inhibiting secretion of the gluconeogenic hormone glucagon. These actions, which are mostly mediated via a glucose-sensitive part of the brain stem, the area postrema, may be over-ridden during hypoglycemia. They collectively reduce the total insulin demand.cite journal |author=Ratner RE, Dickey R, Fineman M, Maggs DG, Shen L, Strobel SA, Weyer C, Kolterman OG |title=Amylin replacement with pramlintide as an adjunct to insulin therapy improves long-term glycaemic and weight control in Type 1 diabetes mellitus: a 1-year, randomized controlled trial|journal=Diabet Med |volume= 21 |issue= 11|pages=1204–12 |year= 2004 | pmid = 15498087 |doi=10.1111/j.1464-5491.2004.01319.x]

Rodent amylin knockouts are known to fail to achieve the normal anorexia following food consumption. Because it is an amidated peptide, like many neuropeptides, it is believed to be responsible for the anorectic effect.

tructure

The human form of IAPP has the amino acid sequence KCNTATCATQRLANFLVHSSNNFGAILSSTNVGSNTY, with a disulfide bridge between cysteine residues 2 and 7. The peptide is secreted from the pancreas into the blood circulation and eventually excreted by the kidneys. IAPP is capable of forming amyloid fibrils "in vitro". Within the fibrillization reaction, the early prefibrillar structures are extremely toxic to beta-cell and insuloma cell cultures. Later amyloid fibril structures also seem to have some cytotoxic effect on cell cultures. Rats and mice have six substitutions (three of which are proline substitions at positions 25, 28 and 29) that are believed to prevent the formation of amyloid fibrils. Studies have shown that fibrils are the end product and not necessarily the most toxic form of amyloid proteins/peptides in general. A non-fibril forming peptide (1-19 residues of human amylin) is toxic like the full-length peptide but the respective segment of rat amylin is not.cite journal | author = Brender JR, Lee EL, Cavitt MA, Gafni A, Steel DG, Ramamoorthy A | title = Amyloid fiber formation and membrane disruption are separate processes localized in two distinct regions of IAPP, the type-2-diabetes-related peptide | journal = J. Am. Chem. Soc. | volume = 130 | issue = 20 | pages = 6424–9 | year = 2008 | month = May | pmid = 18444645 | doi = 10.1021/ja710484d | url = | issn = ] . It was also demonstrated by solid-state NMR spectroscopy that the fragment 20-29 of the human-amylin fragments membranes.cite journal | author = Brender JR, Dürr UH, Heyl D, Budarapu MB, Ramamoorthy A | title = Membrane fragmentation by an amyloidogenic fragment of human Islet Amyloid Polypeptide detected by solid-state NMR spectroscopy of membrane nanotubes | journal = Biochim. Biophys. Acta | volume = 1768 | issue = 9 | pages = 2026–9 | year = 2007 | month = September | pmid = 17662957 | pmc = 2042489 | doi = 10.1016/j.bbamem.2007.07.001 | url = | issn = ]

History and Nomenclature

IAPP was identified independently by two groups as the major component of diabetes-associated islet amyloid deposits in 1987.cite journal |author=Cooper GJ, Willis AC, Clark A, Turner RC, Sim RB, Reid KB |title=Purification and characterization of a peptide from amyloid-rich pancreases of type 2 diabetic patients|journal=Proc Natl Acad Sci USA |volume= 84 |issue= 23|pages=8628–32 |year= 1987 | pmid = 3317417 |doi=10.1073/pnas.84.23.8628] cite journal |author=Westermark P, Wernstedt C, Wilander E, Hayden DW, O'Brien TD, Johnson KH |title=Amyloid fibrils in human insulinoma and islets of Langerhans of the diabetic cat are derived from a neuropeptide-like protein also present in normal islet cells|journal=Proc Natl Acad Sci USA |volume= 84 |issue= 11|pages=3881–3885 |year= 1987 | pmid = 3035556 |doi=10.1073/pnas.84.11.3881]

The difference in nomenclature is largely geographical; European researchers tend to prefer IAPP whereas American researchers tend to prefer Amylin. Some researchers discourage the use of "Amylin" on the grounds that it may be confused with the pharmaceutical company.Fact|date=August 2008

Pharmacology

Synthetic amylin, or pramlintide (brand name Symlin), was recently approved for adult use in patients with both diabetes mellitus type 1 and diabetes mellitus type 2. Insulin and pramlintide, injected separately but both before a meal, work together to control the post-prandial glucose excursion.cite web | url = http://www.amylin.com/pipeline/symlin.cfm/ | title = SYMLIN (pramlintide acetate) | author = | authorlink = | coauthors = | date = 2006 | format = | work = | publisher = Amylin Pharmaceuticals, Inc.| pages = | language = | archiveurl = | archivedate = | quote = | accessdate = 2008-05-28]

Amylin is degraded in part by insulin-degrading enzyme.cite journal | author = Shen Y, Joachimiak A, Rosner MR, Tang WJ | title = Structures of human insulin-degrading enzyme reveal a new substrate recognition mechanism | journal = Nature | volume = 443 | issue = 7113 | pages = 870–4 | year = 2006 | month = October | pmid = 17051221 | doi = 10.1038/nature05143 | url = ]

Receptors

There appears to be at least three distinct receptor complexes that bind with high affinity to amylin. All three complexes contain the calcitonin receptor at the core, plus one of three receptor activity-modifying proteins, RAMP1, RAMP2, or RAMP3.cite journal |author=Hay DL, Christopoulos G, Christopoulos A, Sexton PM |title=Amylin receptors: molecular composition and pharmacology|journal=Biochem Soc Trans |volume= 32 |issue= 5|pages=865–7 |year= 2004 | pmid = 15494035 |doi=10.1042/BST0320865]

References

Further reading

PBB_Further_reading
citations =
*cite journal | author=Pittner RA, Albrandt K, Beaumont K, "et al." |title=Molecular physiology of amylin |journal=J. Cell. Biochem. |volume=55 Suppl |issue= |pages= 19–28 |year= 1994 |pmid= 7929615 |doi=
*cite journal | author=Hayden MR |title=Islet amyloid, metabolic syndrome, and the natural progressive history of type 2 diabetes mellitus |journal=JOP |volume=3 |issue= 5 |pages= 126–38 |year= 2002 |pmid= 12221327 |doi=
*cite journal | author=Westermark P, Andersson A, Westermark GT |title=Is aggregated IAPP a cause of beta-cell failure in transplanted human pancreatic islets? |journal=Curr. Diab. Rep. |volume=5 |issue= 3 |pages= 184–8 |year= 2005 |pmid= 15929864 |doi=
*cite journal | author=Höppener JW, Oosterwijk C, Visser-Vernooy HJ, "et al." |title=Characterization of the human islet amyloid polypeptide/amylin gene transcripts: identification of a new polyadenylation site |journal=Biochem. Biophys. Res. Commun. |volume=189 |issue= 3 |pages= 1569–77 |year= 1993 |pmid= 1282806 |doi=
*cite journal | author=Hubbard JA, Martin SR, Chaplin LC, "et al." |title=Solution structures of calcitonin-gene-related-peptide analogues of calcitonin-gene-related peptide and amylin |journal=Biochem. J. |volume=275 ( Pt 3) |issue= |pages= 785–8 |year= 1991 |pmid= 2039456 |doi=
*cite journal | author=Butler PC, Chou J, Carter WB, "et al." |title=Effects of meal ingestion on plasma amylin concentration in NIDDM and nondiabetic humans |journal=Diabetes |volume=39 |issue= 6 |pages= 752–6 |year= 1990 |pmid= 2189768 |doi=
*cite journal | author=van Mansfeld AD, Mosselman S, Höppener JW, "et al." |title=Islet amyloid polypeptide: structure and upstream sequences of the IAPP gene in rat and man |journal=Biochim. Biophys. Acta |volume=1087 |issue= 2 |pages= 235–40 |year= 1990 |pmid= 2223885 |doi=
*cite journal | author=Christmanson L, Rorsman F, Stenman G, "et al." |title=The human islet amyloid polypeptide (IAPP) gene. Organization, chromosomal localization and functional identification of a promoter region |journal=FEBS Lett. |volume=267 |issue= 1 |pages= 160–6 |year= 1990 |pmid= 2365085 |doi=
*cite journal | author=Clark A, Edwards CA, Ostle LR, "et al." |title=Localisation of islet amyloid peptide in lipofuscin bodies and secretory granules of human B-cells and in islets of type-2 diabetic subjects |journal=Cell Tissue Res. |volume=257 |issue= 1 |pages= 179–85 |year= 1989 |pmid= 2546670 |doi=
*cite journal | author=Nishi M, Sanke T, Seino S, "et al." |title=Human islet amyloid polypeptide gene: complete nucleotide sequence, chromosomal localization, and evolutionary history |journal=Mol. Endocrinol. |volume=3 |issue= 11 |pages= 1775–81 |year= 1990 |pmid= 2608057 |doi=
*cite journal | author=Mosselman S, Höppener JW, Lips CJ, Jansz HS |title=The complete islet amyloid polypeptide precursor is encoded by two exons |journal=FEBS Lett. |volume=247 |issue= 1 |pages= 154–8 |year= 1989 |pmid= 2651160 |doi=
*cite journal | author=Roberts AN, Leighton B, Todd JA, "et al." |title=Molecular and functional characterization of amylin, a peptide associated with type 2 diabetes mellitus |journal=Proc. Natl. Acad. Sci. U.S.A. |volume=86 |issue= 24 |pages= 9662–6 |year= 1990 |pmid= 2690069 |doi=
*cite journal | author=Westermark P, Wernstedt C, Wilander E, "et al." |title=Amyloid fibrils in human insulinoma and islets of Langerhans of the diabetic cat are derived from a neuropeptide-like protein also present in normal islet cells |journal=Proc. Natl. Acad. Sci. U.S.A. |volume=84 |issue= 11 |pages= 3881–5 |year= 1987 |pmid= 3035556 |doi=
*cite journal | author=Sanke T, Bell GI, Sample C, "et al." |title=An islet amyloid peptide is derived from an 89-amino acid precursor by proteolytic processing |journal=J. Biol. Chem. |volume=263 |issue= 33 |pages= 17243–6 |year= 1988 |pmid= 3053705 |doi=
*cite journal | author=Mosselman S, Höppener JW, Zandberg J, "et al." |title=Islet amyloid polypeptide: identification and chromosomal localization of the human gene |journal=FEBS Lett. |volume=239 |issue= 2 |pages= 227–32 |year= 1988 |pmid= 3181427 |doi=
*cite journal | author=Cooper GJ, Willis AC, Clark A, "et al." |title=Purification and characterization of a peptide from amyloid-rich pancreases of type 2 diabetic patients |journal=Proc. Natl. Acad. Sci. U.S.A. |volume=84 |issue= 23 |pages= 8628–32 |year= 1988 |pmid= 3317417 |doi=
*cite journal | author=Westermark P, Wernstedt C, Wilander E, Sletten K |title=A novel peptide in the calcitonin gene related peptide family as an amyloid fibril protein in the endocrine pancreas |journal=Biochem. Biophys. Res. Commun. |volume=140 |issue= 3 |pages= 827–31 |year= 1986 |pmid= 3535798 |doi=
*cite journal | author=Lorenzo A, Razzaboni B, Weir GC, Yankner BA |title=Pancreatic islet cell toxicity of amylin associated with type-2 diabetes mellitus |journal=Nature |volume=368 |issue= 6473 |pages= 756–60 |year= 1994 |pmid= 8152488 |doi= 10.1038/368756a0
*cite journal | author=Höppener JW, Verbeek JS, de Koning EJ, "et al." |title=Chronic overproduction of islet amyloid polypeptide/amylin in transgenic mice: lysosomal localization of human islet amyloid polypeptide and lack of marked hyperglycaemia or hyperinsulinaemia |journal=Diabetologia |volume=36 |issue= 12 |pages= 1258–65 |year= 1994 |pmid= 8307253 |doi=
*cite journal | author=Lim YA, Ittner LM, Lim YL, Götz J. |title=Human but not rat amylin shares neurotoxic properties with Abeta42 in long-term hippocampal and cortical cultures.|journal=FEBS Lett|volume= 582 |issue= 15 |pages= 2188-2194 |year= 2008 |pmid= 18486611 |doi=

External links

*
*

PBB_Controls
update_page = yes
require_manual_inspection = no
update_protein_box = yes
update_summary = yes
update_citations = yes